Turgay İşbir
- Molecular Biology top 10%
- Cardiology and Cardiovascular Medicine top 5%
- Surgery top 10%
- Pathology and Forensic Medicine top 5%
- Oncology top 10%
- Co-authors
- Hülya YılmazBedia AğaçhanArzu ErgenH.W. ReadingUzay GörmüşZeynep KaraaliSeda Güleç Yılmazİlhan Yaylım
- Topics
- Paraoxonase enzyme and polymorphisms (17 papers)Folate and B Vitamins Research (16 papers)Lipoproteins and Cardiovascular Health (10 papers)
- Partner nations
- TürkiyeUnited KingdomCzechia
In The Last Decade
Turgay İşbir
184 papers receiving 2.6k citations
Peers
Comparison fields: 5 of 126
- Molecular Biology 962
- Cardiology and Cardiovascular Medicine 380
- Surgery 367
- Pathology and Forensic Medicine 328
- Oncology 320
Countries citing papers authored by Turgay İşbir
This map shows the geographic impact of Turgay İşbir's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Turgay İşbir with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Turgay İşbir more than expected).
Fields of papers citing papers by Turgay İşbir
This network shows the impact of papers produced by Turgay İşbir. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Turgay İşbir. The network helps show where Turgay İşbir may publish in the future.
Co-authorship network of co-authors of Turgay İşbir
This figure shows the co-authorship network connecting the top 25 collaborators of Turgay İşbir. A scholar is included among the top collaborators of Turgay İşbir based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Turgay İşbir. Turgay İşbir is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 0 | |
| 4 | Functional genetic variants in apoptosis-associated FAS and FASL genes and risk of bladder cancer in a Turkish population. | 7 |
| 5 | 11 | |
| 6 | The significance of HSP90AA1, HSP90AB1 and HSP90B1 gene polymorphisms in a Turkish population with non-small cell lung cancer. | 23 |
| 7 | 7 | |
| 8 | 13 | |
| 9 | 5 | |
| 10 | 17 | |
| 11 | Associations of -374T/A polymorphism of receptor for advanced glycation end products (RAGE) gene in Turkish diabetic and non-diabetic patients with coronary artery disease. | 13 |
| 12 | CYP17 (T-34C) and CYP19 (Trp39Arg) polymorphisms and their cooperative effects on breast cancer susceptibility. | 12 |
| 13 | Possible associations of APE1 polymorphism with susceptibility and HOGG1 polymorphism with prognosis in gastric cancer. | 66 |
| 14 | Bladder cancer and polymorphisms of DNA repair genes (XRCC1, XRCC3, XPD, XPG, APE1, hOGG1). | 60 |
| 15 | 7 | |
| 16 | 40 | |
| 17 | 39 | |
| 18 | 28 | |
| 19 | 46 | |
| 20 | 9 |
About Turgay İşbir
Turgay İşbir is a scholar working on Clinical Biochemistry, Rheumatology and Obstetrics and Gynecology, having authored 192 papers that have together received 2.7k indexed citations. Recurring topics across this work include Paraoxonase enzyme and polymorphisms (17 papers), Folate and B Vitamins Research (16 papers) and Lipoproteins and Cardiovascular Health (10 papers). The work is most often cited by research in Clinical Biochemistry (280 citations), Rheumatology (304 citations) and Obstetrics and Gynecology (150 citations). Turgay İşbir has collaborated with scholars based in Türkiye, United Kingdom and Czechia. Frequent co-authors include Hülya Yılmaz, Bedia Ağaçhan, Arzu Ergen, H.W. Reading, Uzay Görmüş, Zeynep Karaali, Seda Güleç Yılmaz, İlhan Yaylım, Fehmi Narter and Oğuz Öztürk. Their work appears in journals such as Proceedings of the National Academy of Sciences, Gene and Biochemical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.